D&D Pharmatech (347850.KQ)

KRW 47200.0

(0.21%)

EBITDA Summary of D&D Pharmatech

D&D Pharmatech's latest annual EBITDA in 2023 was -9.05 Billion KRW , up 89.83% from previous year.
D&D Pharmatech's latest quarterly EBITDA in 2024 Q2 was -4.91 Billion KRW , down -16.55% from previous quarter.
D&D Pharmatech reported an annual EBITDA of -90.87 Billion KRW in 2022, down -44.39% from previous year.
D&D Pharmatech reported an annual EBITDA of -62.93 Billion KRW in 2021, down -11.27% from previous year.
D&D Pharmatech reported a quarterly EBITDA of -4.22 Billion KRW for 2024 Q1, down -46.33% from previous quarter.
D&D Pharmatech reported a quarterly EBITDA of -3.02 Billion KRW for 2023 Q4, down -415.67% from previous quarter.

Annual EBITDA Chart of D&D Pharmatech (2023 - 2019)

Historical Annual EBITDA of D&D Pharmatech (2023 - 2019)

Year	EBITDA	EBITDA Growth
2023	-9.05 Billion KRW	89.83%
2022	-90.87 Billion KRW	-44.39%
2021	-62.93 Billion KRW	-11.27%
2020	-56.56 Billion KRW	-143.02%
2019	-23.27 Billion KRW	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-4.91 Billion KRW	-16.55%
2024 Q1	-4.22 Billion KRW	-46.33%
2023 Q4	-3.02 Billion KRW	-415.67%
2023 FY	- KRW	89.83%
2023 Q3	959.46 Million KRW	-81.52%
2023 Q2	5.19 Billion KRW	243.3%
2023 Q1	-3.62 Billion KRW	90.53%
2022 FY	- KRW	-44.39%
2022 Q4	-38.26 Billion KRW	0.0%
2021 FY	- KRW	-11.27%
2020 FY	- KRW	-143.02%
2019 FY	- KRW	0.0%

Peer EBITDA Comparison of D&D Pharmatech

Name	EBITDA	EBITDA Difference
HLB Co., Ltd.	-172.27 Billion KRW	94.742%
iNtRON Biotechnology, Inc.	-6.23 Billion KRW	-45.283%
BINEX Co., Ltd.	10.87 Billion KRW	183.314%
Bioneer Corporation	10.04 Billion KRW	190.189%
Anterogen.Co.,Ltd.	-437.82 Million KRW	-1968.843%
MEDIPOST Co., Ltd.	-19.39 Billion KRW	53.29%
CrystalGenomics, Inc.	-42.79 Billion KRW	78.835%
Helixmith Co., Ltd	-53 Billion KRW	82.911%
Chabiotech Co.,Ltd.	70.08 Billion KRW	112.924%
Medy-Tox Inc.	32.69 Billion KRW	127.702%
Peptron, Inc.	-12.65 Billion KRW	28.399%
Amicogen, Inc.	13.95 Billion KRW	164.917%
Genexine, Inc.	-40.87 Billion KRW	77.842%
HLB Therapeutics Co.,Ltd.	8.22 Billion KRW	210.065%
LegoChem Biosciences, Inc.	-71.38 Billion KRW	87.311%
ALTEOGEN Inc.	440.04 Million KRW	2158.419%
PharmaResearch Co., Ltd.	104.25 Billion KRW	108.688%
SillaJen, Inc.	-17.35 Billion KRW	47.801%
JETEMA, Co., Ltd.	11 Billion KRW	182.287%
OliX Pharmaceuticals,Inc	-11.13 Billion KRW	18.654%
Genomictree Inc.	-6.33 Billion KRW	-43.053%
MedPacto, Inc.	-32.6 Billion KRW	72.222%
EASY BIO,Inc.	24.32 Billion KRW	137.24%
GI Innovation, Inc.	-51.33 Billion KRW	82.354%